Clinical Trials

Triple Negative Breast Neoplasms

NCT06590558 2025-07-03

Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer

Triple Negative Breast Neoplasms

NCT03554109 2025-02-21

TNBC

Triple Negative Breast Neoplasms

NCT03473691 2024-12-09

Breast50

Triple Negative Breast Neoplasms

NCT06057636 2024-05-10

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

Phase NA Withdrawn

Cancer Pain, Agnosia, Breast Neoplasms, Neoplasm Metastasis, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05209529 2024-02-23

Chemo-free BRCA-targeted Neoadjuvant Strategy

Triple Negative Breast Neoplasms

NCT04602117 2023-11-18

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05809895 2023-07-24

AdvanTIG-211

Triple Negative Breast Neoplasms

NCT05255666 2023-07-11

Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

BreastCNS

Brain Neoplasms, Triple Negative Breast Neoplasms

NCT05774886 2023-05-18

Implantable Microdevice for TNBC - Pilot Study

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05368506 2023-05-06

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

BreastGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT03982173 2023-01-26

MATILDA

BreastGastrointestinal

Adenocarcinoma Of Esophagus, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT04249167 2023-01-06

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Triple Negative Breast Neoplasms

NCT04291950 2022-12-20

Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women

Withdrawn

BreastOther

Breast Neoplasms, Obesity, Overweight, Triple Negative Breast Neoplasms

NCT05062174 2022-12-15

Breast Cancer BRCA1 Carriers: a Pilot Study

Withdrawn

BreastCNSGastrointestinalGynecologic

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT02201381 2022-07-18

METRICS

Phase 3 Withdrawn

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT05234606 2022-04-12

A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

Phase 1/2 Withdrawn

BreastGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Triple Negative Breast Neoplasms

NCT05008510 2022-02-08

VERU-111

Triple Negative Breast Neoplasms

NCT02161679 2021-08-19

Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer

Triple Negative Breast Neoplasms

NCT04067102 2021-07-09

Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC

Phase NA Withdrawn

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Triple Negative Breast Neoplasms

NCT04464967 2021-05-12

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04142554 2020-11-03

LCCC1820

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04149444 2020-06-11

TACTIC

Triple Negative Breast Neoplasms

NCT03644589 2019-04-26

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03326258 2018-07-18

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Phase 1/2 Withdrawn

BreastDermatologic

Uveal Melanoma, Breast Neoplasms, Melanoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT03045393 2018-07-05

IMGN853

BreastGastrointestinalThoracic

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01936961 2017-06-27

I-CREST

Phase NA Withdrawn

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

NCT02567396 2017-04-24

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction